A Novel Anti-TRPV6 Antibody and Its Application in Cancer Diagnosis In Vitro.
Aurélien HaustrateAdriana MihalacheClément CordierPierre GossetNatalia PrevarskayaV'yacheslav Lehen'kyiPublished in: International journal of molecular sciences (2022)
Though the first discovery of TRPV6 channel expression in various tissues took place in the early 2000s, reliable tools for its protein detection in various cells and tissues are still missing. Here we show the generation and validation of rabbit polyclonal anti-TRPV6 channel antibodies (rb79-82) against four epitopes of 15 amino acids. Among them, only one antibody, rb79, was capable of detecting the full-length glycosylated form of the TRPV6 channel at around 100 kDa. The generated antibody was shown to be suitable for all in vitro applications, such as immunoblotting, immunoprecipitation, immunocytochemistry, immunofluorescence, etc. One of the most important applications is immunohistochemistry using the paraffin-embedded sections from cancer resection specimens. Using prostate cancer resection specimens, we have confirmed the absence of the TRPV6 protein in both healthy and benign hyperplasia, as well as its expression and correlation to the prostate cancer grades. Thus, the generated rabbit polyclonal anti-TRPV6 channel antibody rb79 is suitable for all in vitro diagnostic applications and particularly for the diagnosis in clinics using paraffin-embedded sections from patients suffering from various diseases and disorders involving the TRPV6 channel.
Keyphrases
- prostate cancer
- neuropathic pain
- amino acid
- poor prognosis
- gene expression
- radical prostatectomy
- primary care
- binding protein
- induced apoptosis
- ejection fraction
- spinal cord
- newly diagnosed
- squamous cell carcinoma
- spinal cord injury
- squamous cell
- signaling pathway
- oxidative stress
- protein protein
- endoplasmic reticulum stress
- single cell
- long non coding rna
- patient reported outcomes
- real time pcr
- ultrasound guided